Glucocorticoid-loaded nanoparticles for prevention of corneal allograft rejection and neovascularization
US-2017157147-A1 · Jun 8, 2017 · US
US11806355B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11806355-B2 |
| Application number | US-201816493368-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 12, 2018 |
| Priority date | Mar 14, 2017 |
| Publication date | Nov 7, 2023 |
| Grant date | Nov 7, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to compositions containing water-soluble poly(oxazoline) and organic polymer particles chosen from the group of polyolefins, polyvinyl aromatics, polyvinyl esters, polyesters, polyamides, polyimides, polycarboxylic acids, polycarboxilic acid esters, polycarboxylic acid amides, polynitriles, polysulfonic acids, polyketones, polysulfones, polymeric polyols, polyurethanes, proteins, polymeric carbohydrates, nucleic acids or from a mixture of two or more of these polymers. The water-soluble poly(oxazolin) acts as a stabilizer for the polymer particles and can particularly advantageously be used as a stabilizer in the freeze-drying of aqueous polymer dispersions.
Opening claim text (preview).
The invention claimed is: 1. A composition comprising a water-soluble poly(oxazoline) compound and organic polymer particles, wherein the organic polymer particles comprise a polyester; a mean diameter D 50 of the organic polymer particles is less than 10 μm; and the water-soluble poly(oxazoline) compound is not covalently bonded to the polymeric particles. 2. The composition according to claim 1 , characterized in that the polyester is a polyhydroxyalkanoate. 3. The composition according to claim 2 , characterized in that the polyhydroxyalkanoate is a lactic acid homo- or copolymer. 4. A composition comprising a water-soluble poly(oxazoline) compound and organic polymer particles, wherein a mean diameter D 50 of the organic polymer particles is less than 10 μm; the organic particles being selected from the group of polyolefins, polyvinylaromatics, polyvinyl esters, polyesters, polyamides, polyimides, polycarboxylic acids, polycarboxylic acid esters, polycarboxylic acid amides, polynitriles, polysulfonic acids, polyketones, polysulfones, polymeric polyols, polyurethanes, proteins, polymeric carbohydrates, nucleic acids or a mixture of two or more of these polymers; the organic polymer particles contain one or more pharmaceutically active substances; and the water-soluble poly(oxazoline) compound is not covalently bonded to the organic polymeric particles. 5. The composition according to 1 , wherein the organic polymer particles have diameters in the range of 50 to 999 nm. 6. The composition according to claim 1 , wherein the organic polymer particles form a dispersed phase in a hydrophilic liquid. 7. The composition according to claim 4 , wherein the organic polymer particles are in solid form and are coated by the poly(oxazoline). 8. The composition according to 4 , wherein the organic polymer particles have diameters in the range of 50 to 999 nm. 9. The composition according to claim 4 , wherein the organic polymer particles form a dispersed phase in a hydrophilic liquid. 10. The composition according to claim 4 , wherein the organic polymer particles are in solid form and are coated by the poly(oxazoline). 11. The composition according to claim 4 , wherein the organic polymer particles comprise a polyester. 12. The composition of claim 1 , wherein at least 90 wt % of the water-soluble poly(oxazoline) compound has a recurring structural unit of formula I: —NR 1 —CR 3 H—CR 4 H— (I), wherein R 1 is —CO—R 2 with R 2 being hydrogen or methyl or ethyl; and R 3 , R 4 are independently hydrogen, methyl, ethyl, propyl, or butyl. 13. The composition of claim 12 , wherein at least 95 wt % of the water-soluble poly(oxazoline) compound has the recurring structural unit of formula I. 14. The composition of claim 1 , wherein the water-soluble poly(oxazoline) is a homopolymer. 15. The composition of claim 4 , wherein at least 90 wt % of the water-soluble poly(oxazoline) compound has a recurring structural unit of formula I: —NR 1 —CR 3 H—CR 4 H— (I), wherein R 1 is —CO—R 2 with R 2 being hydrogen or methyl or ethyl; and R 3 , R 4 are independently hydrogen, methyl, ethyl, propyl, or butyl. 16. The composition of claim 15 , wherein at least 95 wt % of the water-soluble poly(oxazoline) compound has the recurring structural unit of formula I. 17. The composition of claim 4 , wherein the water-soluble poly(oxazoline) is a homopolymer. 18. The composition of claim 4 , further comprising an auxiliary agent and/or an additive.
having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine · CPC title
Polyesters, e.g. poly(lactide-co-glycolide) · CPC title
Polyesters derived from hydroxycarboxylic acids, e.g. lactones (C08L67/06 takes precedence) · CPC title
Anti-settling agents · CPC title
macromolecular (C09D7/41-C09D7/48 take precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.